Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label amenable to exon 53 skipping therapy.. Show all posts
Showing posts with label amenable to exon 53 skipping therapy.. Show all posts
Thursday, December 31, 2020

FDA Approves Viltepso (viltolarsen) for the Treatment of Duchenne Muscular Dystrophy in Patients Amenable to Exon 53 Skipping Therapy

›
NS Pharma, Inc. announced  the U.S. Food & Drug Administration (FDA) has approved Viltepso (viltolarsen) injection for patients with Duc...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.